Apollomics
is a California-based biopharmaceutical company that discovers, develops, and commercializes therapies for the treatment of cancer... Read moreApollomics
is a California-based biopharmaceutical company that discovers, develops, and commercializes therapies for the treatment of cancer... Read more
News
Apr 01, 2026
Nasdaq
Apollomics: Apollomics Secures $2 Million Bridge Financing To Support Clinical Programs
Dec 23, 2025
Nasdaq
Apollomics: Apollomics H1 Loss Narrows
Dec 22, 2025
Marketscreener
Apollomics: Apollomics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
Nov 19, 2025
Benzinga
Apollomics: Apollomics Announces Settlement of Cayman Litigation
Oct 15, 2025
GlobalNewswire
Press Release: Apollomics : Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
Oct 14, 2025
GlobeNewswire
Press Release: Apollomics : Nasdaq Resumes Trading in Apollomics Inc.
Oct 14, 2025
Life Care News
Apollomics: Apollomics, Inc. Company Operational Continuity Update
Jun 11, 2025
Owler
Apollomics, Inc.: Apollomics's employee count changed from 45 in Dec 2023 to 13 in Dec 2024
Apr 04, 2025
centralcharts
Press Release: Apollomics : Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Apr 03, 2025
Marketscreener
Apollomics: Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Apollomics Competitors
1
2
3
4
5
6
7
8
9
10